Seer, Inc. SEER 1.93 Seer, Inc.

Home
  /  
Stock List  /  Seer, Inc.
Range:1.455-2.3Vol Avg:329682Last Div:0Changes:-0.01
Beta:1.47Cap:0.12BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Fri Dec 04 2020Empoloyees:147
CUSIP:81578P106CIK:0001726445ISIN:US81578P1066Country:US
CEO:Dr. Omid C. Farokhzad M.D., Ph.D.Website:https://seer.bio
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow